# TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

> **NCT04094818** · — · COMPLETED · sponsor: **Inflammatix** · enrollment: 1441 (actual)

## Conditions studied

- Respiratory Tract Infections
- Urinary Tract Infections
- Intra-Abdominal Infections
- Skin and Soft Tissue Infection
- Suspected Meningitis/Encephalitis or Any Other Infection
- Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** TriVerity

## Key facts

- **NCT ID:** NCT04094818
- **Lead sponsor:** Inflammatix
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-28
- **Primary completion:** 2024-08-06
- **Final completion:** 2024-09-30
- **Target enrollment:** 1441 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094818, "TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04094818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*